Author

Geeta George

Institutions: Mayo Clinic, University of Pavia, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo, Universitat de Barcelona

Observed institutions: Mayo Clinic, University of Pavia, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo, Universitat de Barcelona

OpenAlex ID: A5069626180

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

2010 · Naseema Gangat, Domenica Caramazza, et al. · Journal of Clinical Oncology · 1,058

A Phase I/II Study of CYT387, An Oral JAK-1/2 Inhibitor, In Myelofibrosis: Significant Response Rates In Anemia, Splenomegaly, and Constitutional Symptoms

2010 · Animesh Pardanani, Geeta George, et al. · Blood · 39

DIPSS-Plus: A Refined Dynamic International Prognostic Scoring System (DIPSS) for Primary Myelofibrosis That Incorporates Karyotype, Platelet Count and Transfusion Status

2010 · Naseema Gangat, Domenica Caramazza, et al. · Blood · 3

Works count: 3

Citation count: 1,099

H-index: 3

I10-index: 2